Physician

Vijay K Gunuganti, M.D.

According to 2025 Medicare claims, Vijay Gunuganti, M.D. (NPI: 1073535076) practices medical oncology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78258-4890. Gunuganti is affiliated with the Prime Accountable Care East LLC (ACO ID: D0343), participating under the REACH model.

Gunuganti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 763 traditional Medicare patients, billed 207,558 HCPCS/CPT codes, and received $3,796,382 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,828 prescription claims across 386 beneficiaries totaling $3,222,125 in drug costs, led by Revlimid (Lenalidomide). DME data shows 136 claims. Open Payments data shows 190 records totaling $434,079. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,818,998 to $3,796,382. Similarly, Part D prescription costs have risen steadily, from $1,558,708 to $3,222,125. In contrast, DME billing represents a smaller volume and rose steadily, from $9,124 to $22,539.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	418	192,999	$1,818,998
2016	566	213,316	$2,466,652
2017	582	241,567	$3,271,081
2018	634	219,154	$3,317,192
2019	746	255,404	$4,016,476
2020	704	251,586	$4,627,918
2021	745	280,676	$4,848,032
2022	775	259,934	$5,080,021
2023	767	207,416	$3,453,875
2024	763	207,558	$3,796,382

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	159	1,051	$1,558,708
2016	163	1,079	$1,524,273
2017	192	1,152	$1,613,546
2018	247	1,429	$2,006,494
2019	350	2,839	$2,399,393
2020	336	3,182	$2,749,831
2021	374	3,818	$2,152,480
2022	371	3,627	$1,914,034
2023	418	4,697	$3,150,596
2024	386	4,828	$3,222,125

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	107	$6,123
2016	N/R	127	$15,538
2017	N/R	12	$329
2018	N/R	N/R	N/R
2019	N/R	22	$878
2020	N/R	94	$4,580
2021	13	140	$13,840
2022	N/R	110	$2,712
2023	59	254	$39,079
2024	29	136	$16,537

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	303	825	$91
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	155	713	$43
80053	Blood test, comprehensive group of blood chemicals	290	1,089	$10
36415	Insertion of needle into vein for collection of blood sample	326	1,250	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	342	1,324	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	37	959	$575,477
Lenalidomide	Lenalidomide	36	966	$315,101
Fotivda	Tivozanib Hcl	12	336	$262,200
Erleada	Apalutamide	14	450	$235,021
Nubeqa	Darolutamide	17	486	$201,475

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6021	Collagen dressing, sterile, size 16 sq. in. or less, each	N	18	30	$10,007
A6235	Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing	N	11	13	$2,609
E0303	Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, with mattress	Y	N/R	11	$1,302
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	18	$898
J8521	Capecitabine, oral, 500 mg	N	N/R	13	$721

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	168	$211,175	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	22	$222,904	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vijay K. Gunuganti, M.D.?

Tedicare shows public-source Medicare data for Vijay K. Gunuganti, M.D. (NPI 1073535076), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vijay K. Gunuganti, M.D. have ACO affiliation data?

Vijay K. Gunuganti, M.D. is shown with ACO affiliation data for Prime Accountable Care East LLC (REACH, ACO ID D0343).

What billing organization is linked to Vijay K. Gunuganti, M.D.?

Vijay K. Gunuganti, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Vijay K. Gunuganti, M.D. have Open Payments data?

Vijay K. Gunuganti, M.D. has 190 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.